24/7 Market News: Kraig Labs Unlocks Spider Silk at Scale, Solving a Historical Problem for Nature’s Toughest Fiber

Core Insights - Kraig Biocraft Laboratories has achieved a significant milestone by successfully mass-producing spider silk using genetically engineered silkworms, addressing a long-standing challenge in biotechnology [1][2][3] Company Overview - Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) focuses on the development and commercialization of spider silk-based fiber technologies, utilizing a proprietary silkworm-based genetic engineering platform [5] - The company aims to produce high-performance, cost-effective, and scalable spider silk materials for various applications, including defense, performance apparel, technical textiles, and medical uses [5] Technological Breakthrough - The company’s genetically engineered silkworms serve as a factory for spider silk production, enabling a scalable, cost-effective, and sustainable supply chain [2][3] - This breakthrough allows spider silk to transition from laboratory research to practical applications, making it accessible to various industries [3] Market Applications - Interest in Kraig's spider silk technology spans multiple sectors, including: - Inventors creating stronger, lighter wearables or materials [7] - Biomedical engineers developing biodegradable sutures and scaffolds [7] - Defense contractors designing next-generation body armor [7] - Outdoor brands seeking sustainable, high-performance textiles [7] - Robotics teams working on biomimetic actuators or tethers [7]